Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000034724
JPRN-UMIN000034724Completed未知

Special Drug Use Survey of HERNICORE 1.25 units for intradiscal injection in Patients with Lumbar Disc Herniation - HERNICORE Special Drug Use Survey

SEIKAGAKU CORPORATIO0 sites1,862 target enrollmentStarted: November 1, 2018Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
1,862
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor
SEIKAGAKU CORPORATIO

Similar Trials

Completed
Not Applicable
General Drug Use Survey of HERNICORE 1.25 units for intradiscal injection in Patients with Lumbar Disc Herniatio
JPRN-UMIN000034723SEIKAGAKU CORPORATIO3,000
Completed
Not Applicable
A Study of TAK-660 in surgical procedures for people with hemophilia AHemophilia A
JPRN-jRCT2031210173Contact for Clinical Trial Information17
Not yet recruiting
Not Applicable
Special drug use survey of DARZQURO Combination Subcutaneous Injection (Multiple Myeloma)Multiple Myeloma
JPRN-UMIN000044074Janssen Pharmaceutical K.K.200
Completed
Unknown
Special Drug Use-Results Survey of Onoacttachyarrhythmia, atrial fibrillation/atrial flutter in patients with cardiac dysfunction
JPRN-jRCT1080222572ONO PHARMACEUTICAL CO., LTD.800
Recruiting
Not Applicable
Special Drug Use Results Survey for the use of Symtuza in pregnant wome
JPRN-UMIN000037488Janssen Pharmaceutical K.K.3